Search
Feed aggregator
Despite Near 30% Drop in Humira Sales, AbbVie Beats Wall Street’s Q2 Revenue Expectations
While Humira sales were impacted by cheaper biosimilars, AbbVie reported in its second-quarter earnings results Thursday that revenues jumped nearly 45% for Skyrizi and almost 56% for Rinvoq year over year, respectively.
GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
In the largest study of its kind, GSK’s two-drug regimen Dovato demonstrated non-inferior efficacy compared to Gilead Sciences’ three-drug regimen Biktarvy for the treatment of HIV-1.
2024 Job Search Toolkit
BioSpace has updated our Job Search Toolkit, including recent resources to help you succeed with your next job search.
World Pharma News
- How the cheese-noodle principle could help counter Alzheimer's
- New 'sensor' lets researchers watch DNA repair in real time
- The immune system creates its own targets within viruses
- Targeted drug could benefit young patients with invasive sarcoma
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders